Table 2 Concentration of total gangliosides (sum of GM3 and GD3) in human milk subjected to different heat treatments and storage times

From: Application of industrial treatments to donor human milk: influence of pasteurization treatments, storage temperature, and time on human milk gangliosides

  [Total gangliosides] (mg/L)
Storage time No heat treatment HT-1 HT-2 HT-3 HT-4
  Room temperature (23 °C/40% RH) Cold temperature (4 °C) Room temperature (23 °C/40% RH) Cold temperature (4 °C) Room temperature (23 °C/40% RH) Cold temperature (4 °C) Room temperature (23 °C/40% RH) Cold temperature (4 °C) Room temperature (23 °C/40% RH) Cold temperature (4 °C)
Day 7 14.66 ± 0.79 14.56 ± 0.74 14.69 ± 0.43 14.69 ± 0.57 15.35 ± 0.78 15.38 ± 0.96 14.85 ± 0.36 14.98 ± 1.34 14.95 ± 0.38 14.96 ± 0.94
Day 30 14.51 ± 0.175 14.59 ± 0.60 14.43 ± 0.67 14.69 ± 0.51 15.21 ± 0.38 15.33 ± 0.37 14.93 ± 0.80 14.97 ± 0.44 15.27 ± 0.30 15.37 ± 0.67
Day 60 14.46 ± 0.468 14.72 ± 0.85 14.60 ± 0.17 14.62 ± 0.10 15.43 ± 0.64 15.44 ± 0.58 14.85 ± 0.29 15.00 ± 0.34 15.03 ± 0.13 15.14 ± 0.66
Day 90 14.40 ± 0.489 14.69 ± 0.25 14.61 ± 0.39 14.66 ± 0.15 15.17 ± 0.58 15.55 ± 0.75 14.84 ± 0.83 14.94 ± 0.17 14.85 ± 0.47 15.08 ± 0.74
  1. Results expressed as mg total ganglioside/L human milk (n = 3). Results expressed as mean ± standard deviation (n = 3)
  2. HT-1 Holder pasteurization (63 °C/30 min), HT-2 standard high-temperature-short-time pasteurization (72 °C/15 s), HT-3 extended shelf-life protocol (127 °C/5 s), HT-4 ultrahigh-temperature pasteurization (140 °C/6 s), RH relative humidity